Monalizumab Biosimilar - Research Grade [ICH5017]
Catalogue Number: ICH5017-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | KLRC1,NKG2A,CD159a,CD94 |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG4 |
| Immunogen: | |
| Application: | FA |
Description
Description: RUO monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.
Additional Text
Gene Name
KLRC1
Concentration
5 mg/ml
Gene ID
3821
Uniprot ID
P26715
Purification
Protein A/G Purified
Antibody Clonality
Recombinant Monoclonal
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Storage Note
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
ICH5017 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations